Research Study

A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy
Principal Investigator 
Martin Gleave

Overview

Body Locations and Systems 
Prostate Cancer
ClinicalTrials.gov# 
NCT02319837
Status 
Recruiting
Study Start/End 
Apr 10, 2015 to Dec 31, 2020
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Maureen Palmer, Study Nurse
Phone 
604-875-5675
Purpose of Study 

The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or radiotherapy or both.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.